Predictive Values of Coagulation/Fibrinolysis Parameters for the Termination of Pregnancy Complicated by Severe Preeclampsia

 

 Buy Article Permissions and Reprints

ABSTRACT

We investigated coagulation/fibrinolysis parameters for significant differences between patients with early-onset severe preeclampsia (< 32 weeks gestation, wG) and those with late-onset severe preeclampsia (≥ 32 wG). A decrease in antithrombin (AT), protein C (PC), and free protein S (PS) activities and an increase in plasmin-α2-plasmin inhibitor complex (PIC), thrombin-antithrombin complex (TAT), and FDP D-dimer (D-dimer) were observed. However, there were no statistical differences between the two groups. Once preeclampsia occurred and it developed severe, the changes in coagulation/fibrinolysis parameters became more severe in spite of early-onset preeclampsia or late-onset preeclampsia. We also investigated coagulation/fibrinolysis abnormalities in 101 patients with severe preeclampsia. A significant increase in WBC, RBC, Hb, Ht, TAT, PIC, and D-dimer and a significant decrease in platelet (Plt) counts and AT activity were observed. ΔPlt (the difference between platelet counts in early gestation and before delivery) was -5.0 × 10

@affil4:⁴ /μL in cases with severe preeclampsia. Among patients with severe preeclampsia, coagulation/fibrinolysis changes before delivery were typical for patients with cesarean section compared with those with successful vaginal delivery. These facts suggest that an excessive hypercoagulable state is associated with the termination of pregnancy resulting from the aggravation of preeclampsia. From the viewpoint of coagulation/fibrinolysis changes, the termination of pregnancy could be recommended when the levels of parameters exceed the following values; ΔPlt >| -6.0 | × 10

@affil4:⁴ /μL, D-dimer > 4 μg/mL, AT activity < 79%, TAT > 26 ng/mL, and PIC > 1.2 μg/mL. Particularly, ΔPlt and D-dimer are useful bedside predictive markers in order to decide the optimal time for the termination of pregnancy in patients with severe preeclampsia.

REFERENCES

• 1 Matsuda Y, Tomosugi T, Maeda Y. Cerebral magnetic resonance angiographic findings in severe preeclampsia.  Gynecol Obstet Invest . 1995;  40 249-252
  PubMedGoogle Scholar
• 2 Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation.  Gynecol Obstet Invest . 1987;  24 170-178
  PubMedGoogle Scholar
• 3 Kelton J G, Hunter D JS, Neame P B. A platelet function defect in pre-eclampsia.  Obstet Gynecol . 1985;  65 107-109
  PubMedGoogle Scholar
• 4 Kobayashi T, Tokunaga N, Sugimura M. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.  Semin Thromb Hemost . 1999;  25 451-454
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Chen J, Ishii M, Wang L, Ishii K, Coughlin S R. Thrombin receptor activation.  J Biol Chem . 1994;  269 16041-16045
  PubMedGoogle Scholar
• 6 Rbiet M J, Plantier J L, Dejana E. Thrombin-induced endothelial cell dysfunction.  Br Med Bull . 1994;  50 936-945
  PubMedGoogle Scholar
• 7 Khatun S, Kanayama N, Belayet H. The impact of vasoactive peptides on nitric oxide production in cultured sympathetic neurons.  Neuroscience . 1999;  93 605-609
  CrossrefPubMedGoogle Scholar
• 8 Khatun S, Kanayama N, Belayet H. Increased concentrations of plasma neuropeptide-Y in patients with eclampsia and preeclampsia.  Am J Obstet Gynecol . 2000;  182 896-900
  PubMedGoogle Scholar
• 9 Page N M, Woods R J, Gardiner S M. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia.  Nature . 2000;  405 797-800
  CrossrefPubMedGoogle Scholar
• 10 Terao T, Kobayashi T, Imai N, Oda H, Karasawa T. Pathological state of the coagulatory and fibrinolytic system in preeclampsia and the possibility of its treatment with AT-III concentrate.  Asia Oceania J Obstet Gynecol . 1989;  15 25-32
  PubMedGoogle Scholar
• 11 Maki M, Kobayashi T, Terao T. Antithrombin therapy for severe preeclampsia: Results of a double blind, randomized, placebo-controlled trial.  Thromb Haemost . 2000;  84 583-590
  PubMedGoogle Scholar
• 12 Dekker G A, de Vries I P J, Doelitzsch P M. Underlying disorders associated with severe early-onset preeclampsia.  Am J Obstet Gynecol . 1995;  173 1042-1048
  CrossrefPubMedGoogle Scholar